Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02772159 · ClinicalTrials.gov registry record · Phase 1
TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
A Phase 1 study, sponsored by Mylan.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT02772159 is a Phase 1 study that has completed, run by Mylan. The registered enrollment target is 9 participants.
The verdict
NCT02772159, a Phase 1 study, has completed, sponsored by Mylan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the absorption, distribution, metabolism and excretion of an investigational medication used to treat chronic obstructive pulmonary disease (COPD). The study drug will be tested in 6 healthy normal males. Dosing will include a single dose of study drug administered via an IV Infusion and an Oral Dose. There will be a 28 day washout period between each of the 2 dosing routes.
Interventions
- DRUG TD-4208
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02772159
The ClinicalTrials.gov registry entry for NCT02772159 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mylan, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TD-4208 is the first listed.
NCT02772159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02772159 about?
NCT02772159 is a clinical study titled "TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects". The purpose of this study is to evaluate the absorption, distribution, metabolism and excretion of an investigational medication used to treat chronic obstructive pulmonary disease (COPD). The study drug will be tested in 6 healthy normal males. Dosing will include a single dose of study drug admini...
What is the current status of trial NCT02772159?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2015-06. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02772159?
The interventions under investigation include: TD-4208 (DRUG).
Who is sponsoring clinical trial NCT02772159?
This trial is sponsored by Mylan, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.